Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1992
11/15/1992CA2068500A1 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings
11/15/1992CA2068434A1 Benzodiazepine analogs
11/15/1992CA2068433A1 Triazolobenzodiazepines
11/15/1992CA2068355A1 Benzodiazephine derivatives, compositions containing them and their use in therapy
11/14/1992CA2068561A1 O-aryl, o-alkyl, o-alkenyl and o-alkynylmacrolides having immunosuppressive activity
11/14/1992CA2068550A1 Method for lowering cholesterol employing bisphosphonate squalene synthetase inhibitors
11/14/1992CA2068388A1 Procedure for the inversion of the sterochemistry at c13 of avermectin aglycone compounds
11/14/1992CA2067974A1 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor
11/14/1992CA2067967A1 Bisphosphonate squalene synthetase inhibitors and method
11/12/1992WO1992020671A1 NOVEL 2H-BENZO[b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS
11/12/1992WO1992019765A1 Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer
11/12/1992WO1992019748A1 Herpesvirus particles and vaccine
11/12/1992WO1992019640A1 A substance for lowering high cholesterol level in serum and a method for preparing the same
11/12/1992WO1992019639A1 Glycosylated prodrugs, method of preparation and use
11/12/1992WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
11/12/1992WO1992019617A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/12/1992WO1992019614A1 4-aryl-3-(heteroarylureido)quinoline derivatives
11/12/1992WO1992019613A2 1,2-dithiole-3-thione derivative-based therapeutical compositions
11/12/1992WO1992019610A1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents
11/12/1992WO1992019607A1 Dibenzothiazepinthione as antiviral agents
11/12/1992WO1992019602A1 Novel pyridazines
11/12/1992WO1992019599A1 Process for the purification of lofepramine by crystallisation
11/12/1992WO1992019598A1 Derivatives of 9-aminoacridine having psychotropic, antiamnestic and lipid regulating properties
11/12/1992WO1992019595A1 Fibrinogen receptor antagonists
11/12/1992WO1992019593A1 Novel immunosuppressive compounds
11/12/1992WO1992019584A1 Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity
11/12/1992WO1992019581A1 4-hydroxy butyric acid derivatives
11/12/1992WO1992019300A1 Perfluorocarbon associated gas exchange
11/12/1992WO1992019278A1 Use of macrolide compounds for eye diseases
11/12/1992WO1992019277A1 Antiviral dibenzothiazepinone derivatives
11/12/1992WO1992019276A1 Dermatologic ointment
11/12/1992WO1992019270A1 Novel combination of medicaments
11/12/1992WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/12/1992WO1992019261A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
11/12/1992WO1992019252A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes
11/12/1992WO1992019245A1 Use of torasemide for the treatment of cerebral oedema
11/12/1992WO1992019244A2 A method for treating infectious respiratory diseases
11/12/1992WO1992019243A1 Liposomal prostaglandin formulations
11/12/1992WO1992019242A1 Free amine benzophenanthridine alkaloid compositions
11/12/1992WO1992019240A1 Treatment of aberrant cellular states with biomodulators
11/12/1992WO1992019239A1 Treatment of aberrant cellular states with biomodulators
11/12/1992WO1992019237A1 Use of a lipid for production of a pharmaceutical enteral preparation for treatment of lipid malabsorption
11/12/1992WO1992019236A1 2-alkylidene-aminoguanidines for inhibiting advanced nonenzymaticglycosylation of proteins
11/12/1992WO1992019233A2 Sustained release composition and methods of use thereof
11/12/1992WO1992019231A1 Pharmaceutical composition comprising an inhibitor of alcohol dehydrogenase
11/12/1992WO1992019228A1 Optimized tablet formulation
11/12/1992WO1992019227A2 Pharmaceutical formulations
11/12/1992WO1992019226A1 A controlled, sustained release delivery system for treating drug dependency
11/12/1992WO1992019225A1 Method for improving the therapeutic efficiency of liposoluble antifungal agents from the imidazole family, and composition for implementing same
11/12/1992WO1992019224A2 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative
11/12/1992WO1992019223A1 N-phenyl-cinnamamides providing protection from the harmful effects of ultraviolet light
11/12/1992WO1992019212A2 Glycine anhydride dimethylol as a biocide and preservative
11/12/1992WO1992019208A1 N-phenyl-benzamides providing protection from the harmful effects of ultraviolet light
11/12/1992WO1992019182A2 Method of attenuation of neointimal proliferation
11/12/1992WO1992019108A1 Treatment of alcohol withdrawal symptoms
11/12/1992WO1992019105A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
11/12/1992WO1992019103A1 Composition and method for treatment of patulous eustachian tube syndrome and atrophic rhinitis
11/12/1992WO1992017469A3 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
11/12/1992WO1992017426A3 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity
11/12/1992WO1992017152A3 Method for detecting and treating alzheimer's disease
11/12/1992WO1992016181A3 Composition for promoting tissue repair and regeneration
11/12/1992WO1992015276A3 Therapeutic and cosmetic compositions for treatment of skin
11/12/1992DE4115465A1 Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen New in the 4-position by aryl or heteroaryl substituted n-2h-benzo (b) pyran derivatives, process for their production and their use as well as the compounds containing preparations
11/12/1992CA2109528A1 A method for treating infectious respiratory diseases
11/12/1992CA2109120A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
11/12/1992CA2109064A1 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2(5h)-furanones as anti-inflammatory agents
11/12/1992CA2107915A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992CA2102904A1 Novel 2h-benzo[b]pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
11/12/1992CA2102212A1 Perfluorocarbon associated gas exchange
11/12/1992CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes
11/11/1992WO1992021049A1 Methods and compositions for inhibiting deposit formation on contact lenses
11/11/1992WO1992020851A1 Sewing machine needle and method of manufacturing same
11/11/1992WO1992020697A1 3'-end blocked oligonucleotides
11/11/1992WO1992020662A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
11/11/1992WO1992020660A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
11/11/1992WO1992000749A1 Anti-herpes virus and cytomegalovirus oligomers
11/11/1992EP0512952A1 Octahydrobenzo (G) quinoline
11/11/1992EP0512939A1 New 2-piperazinylbenzimidazole derivatives
11/11/1992EP0512916A2 Liposomal prostaglandin formulations
11/11/1992EP0512902A1 Dialkyleneperidino compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them
11/11/1992EP0512901A1 Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them
11/11/1992EP0512899A1 Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them
11/11/1992EP0512870A1 Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists
11/11/1992EP0512849A1 Use of deacylated chitin derivatives for the treatment of tumours of the haemopoietic system
11/11/1992EP0512831A1 Fibrinogen receptor antagonists
11/11/1992EP0512829A1 Fibrinogen receptor antagonists
11/11/1992EP0512824A1 Anti-bacterial compound
11/11/1992EP0512817A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications
11/11/1992EP0512814A1 Cosmetic composition
11/11/1992EP0512779A1 Tilmicosine and related compounds for the production of a medicament for the treatment of mastitis
11/11/1992EP0512755A2 Piperazine derivatives
11/11/1992EP0512754A1 Reduction products of rapamycin as immunosuppressants antiinflammatory or antifungal agents
11/11/1992EP0512676A1 Angiotensin II antagonists incorporating a substituted benzyl element
11/11/1992EP0512675A1 Angiotensin II antagonists incorporating a substituted thiophene or furan
11/11/1992EP0512570A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
11/11/1992EP0512547A1 Pain controlling composition and method of preparation
11/11/1992EP0512525A1 Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent, central nervous system stimulant or sigma receptor agonist
11/11/1992EP0512522A1 Novel antibiotic compounds and their production
11/11/1992EP0512419A1 Process for the preparation of high-purity 1-[3'-(chloro)-phenyl]-4-[methyl]-7,8-di-[methoxy]-5H-2,3-benzo diazepine